The global endoluminal suturing devices market was valued at US$ 83.8 Million in 2022 and is expected to reach US$ 295.4 Million by 2033. The endoscopic suturing devices with around 49.4% in terms of value share, has topped the global market within the product category in 2022 and is expected to grow at a CAGR of close to 12.4% over the forecast period (2023 to 2033)
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 83.8 Million |
| Market Value 2023 | US$ 94.9 Million |
| Market Value 2033 | US$ 295.4 Million |
| CAGR 2023 - 2033 | 12.0% |
| Market Share of Top 5 Countries | 52.3% |
The rising incidence of chronic diseases such as cardiovascular disorders, obesity, and gastrointestinal conditions is driving the demand for endoluminal suturing devices. These devices are commonly used in the treatment of conditions such as gastric bypass, hernia repair, and gastrointestinal leaks.
There is a global trend towards minimally invasive surgeries due to their benefits, such as smaller incisions, reduced scarring, and faster recovery. Endoluminal suturing devices enable surgeons to perform complex procedures through small incisions, thereby contributing to the market growth.
Adequate training and education for healthcare professionals on the use of endoluminal suturing devices are essential for their effective and safe utilization. Manufacturers are investing in training programs, workshops, and educational initiatives to ensure proper adoption and maximize the benefits of these devices.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for endoluminal suturing devices was around 36.8% of the overall US$ 227.6 Million of the global suturing devices market in 2022.
Advances in endoluminal suturing devices have improved their accuracy, manoeuvrability, and ease of use. Innovative features, such as real-time imaging and better suturing capabilities, have made these devices more efficient and reliable. Surgeons and healthcare providers are increasingly adopting these advanced devices, contributing to market growth.
Reimbursement policies and insurance coverage for endoluminal suturing procedures vary across different regions. However, favorable reimbursement policies can incentivize healthcare providers to adopt these devices and perform more endoluminal suturing procedures.
Endoluminal suturing devices play a crucial role in enabling minimally invasive procedures by allowing surgeons to suture internally without the need for large incisions. The growing preference for these procedures has boosted the demand for endoluminal suturing devices.
Owed to the above factors, the global market is projected to grow at CAGR of 12.0% in forecasted period.
Endoluminal suturing devices are primarily used in gastrointestinal and cardiovascular procedures. However, there may be opportunities to expand their applications to other surgical areas, such as urology, gynecology, and general surgery. The development of specialized suturing devices for these areas can open up new markets and increase the overall demand for endoluminal suturing devices.
Collaboration between medical device manufacturers and healthcare providers can drive innovation and market penetration. Collaborative efforts can lead to the development of customized endoluminal suturing devices that cater to specific surgical needs. Partnerships with distribution channels also facilitate market access, allowing manufacturers to reach a wider customer base.
There is a constant drive for technological advancements in endoluminal suturing devices. Opportunities exist for the development of devices with improved suturing accuracy, enhanced visualization capabilities, and better ergonomics. Advancements in robotic-assisted suturing technology are likely to open new avenues for growth in the market.
The adoption of endoluminal suturing devices in emerging markets presents significant opportunities. These regions often have a growing patient population and an increasing demand for advanced medical technologies. As healthcare infrastructure improves and economic conditions develop, the market for endoluminal suturing devices in these regions is likely to expand.
Principal Consultant
Endoluminal suturing devices can be expensive, including the initial purchase cost and ongoing maintenance expenses. High cost associated with acquisition and maintenance of these devices can affect their adoption, especially in regions with budget constraints or healthcare systems focused on cost containment. Affordability remains a significant restraint for market growth.
The availability and extent of reimbursement coverage for endoluminal suturing procedures may vary across different regions and healthcare systems. Limited or inadequate reimbursement can affect the adoption of these devices, as healthcare providers may be reluctant to perform procedures without adequate financial compensation. Uncertain reimbursement policies can create challenges for market growth.
Medical devices, including endoluminal suturing devices, are subject to stringent regulatory requirements and approvals. Obtaining regulatory clearance or approval for new devices or product modifications can be a time-consuming and costly process. Compliance with regulations, such as obtaining the necessary certifications, can present challenges to manufacturers, potentially impacting market growth.
The USA occupies 27.0% of market share in 2022 globally. The demand for minimally invasive surgeries is substantial in the United States. Endoluminal suturing devices play a crucial role in enabling these procedures, as they allow surgeons to perform suturing internally through smaller incisions. The increasing adoption of minimally invasive procedures drives the demand for endoluminal suturing devices.
This makes USA prominent market for endoluminal suturing devices in North America.
Japan is the second leading country within East Asia. The market for endoluminal suturing devices in Japan is set to grow at a high CAGR of 13.8% over the forecast period.
Japan is at the forefront of technological advancements in the healthcare industry. The country has a strong focus on research and development, leading to the development of innovative endoluminal suturing devices with advanced features. Japanese companies often introduce cutting-edge technologies and techniques in the field of minimally invasive surgeries, including endoluminal suturing. The availability of favourable reimbursement schemes and the inclusion of endoluminal suturing procedures in insurance coverage influence the adoption and utilization of these devices.
In 2022, the China held a significant share in the East Asia market and contributed around US$ 5.7 Million. The regulatory environment in China has been evolving, with efforts to streamline approval processes and enhance product quality control. The regulation of medical devices in China is overseen by the National Medical Products Administration (NMPA). Manufacturers of endoluminal suturing devices must comply with NMPA regulations to obtain market approval and ensure the safety and efficacy of their products.
Endoluminal suturing devices are used in various clinical applications in China, including gastrointestinal surgeries, cardiovascular procedures, urology, gynecology, and general surgeries. The market encompasses a wide range of surgical specialties where these devices are employed.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By product, endoscopic suturing devices held 49.4% market share in world in 2022.
Endoscopic suturing devices are widely used in gastrointestinal procedures such as closure of gastrointestinal perforations, management of gastrointestinal leaks, closure of post-operative gastric defects, and closure of iatrogenic or traumatic gastrointestinal injuries. Endoscopic Mucosal Resection (EMR) is a technique used to remove abnormal or precancerous tissue from the gastrointestinal tract. Endoscopic suturing devices are used to close the defect or incision created during EMR procedure to prevent complications such as bleeding or perforation.
The market value of gastrointestinal procedures is US$ 36.0 Million, representing a sizable 43.0% market share in 2022. Gastrointestinal perforations can occur due to various reasons, such as ulcers, trauma, or surgical complications. Endoluminal suturing devices are utilized to close these perforations, preventing leakage of gastric contents into the abdominal cavity. The availability of effective endoluminal suturing devices has improved the management of gastrointestinal perforations.
After gastrointestinal surgeries, leaks can occur at the anastomosis site or surgical incisions. Endoluminal suturing devices enable surgeons to close these leaks endoscopically, avoiding the need for additional invasive surgeries. The ability to address gastrointestinal leaks with endoscopic suturing devices has significantly improved patient outcomes and reduced the need for open reoperations.
The hospitals have a considerable presence in the endoscopic suturing devices market, accounting for 43.4% value share in 2022, and exhibiting a high CAGR of 11.6% over the forecast period. Hospitals are prominent users of endoluminal suturing devices. These devices are commonly used in various surgical procedures performed within hospital settings, including gastrointestinal surgeries, cardiovascular procedures, bariatric surgeries, among others. As hospitals strive to provide advanced medical care and meet patient needs, the demand for endoluminal suturing devices is growing.
Endoluminal suturing devices contribute to improve patient outcomes in hospitals. These devices enable surgeons to perform precise suturing, leading to better wound closure, reduced postoperative complications, and shorter hospital stays.
With several players manufacturing endoluminal suturing devices, market has become highly competitive. To gain market share and edge over others, players are undertaking initiatives like acquisition of competitor firms and collaboration with healthcare institutes to develop innovative product lines
Similarly, recent developments related to the companies manufacturing the endoluminal suturing devices have been tracked by the team at Future Market Insights, which are available in the full report.
| Attributes | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa. |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The market is valued at US$ 94.9 million in 2023.
The market’s CAGR from 2023 to 2033 will be 12.0%.
Medtronic Plc., and B Braun Melsungen are the vital market players.
Technological advancements to boost the market prospects.
The endoscopic suturing devices segment is likely to remain preferred through 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption/ Usage Analysis
4.2. Product USPs/ Features
4.3. Reimbursement Scenario
4.4. Regulatory Landscape
4.5. Recent Product Approval/Launches
4.6. PESTEL Analysis
4.7. Porter’s Analysis
4.8. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Suturing Devices Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Cost of Devices
5.2.3. Favourable Government Regulations
5.2.4. Frequency of Product Approvals
5.2.5. Rising Demand for Gastrointestinal Procedures
5.2.6. Technological Advancement in Endoscopic Suturing Devices
5.2.7. Industry Consolidation and Partnerships
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Volume (in Units) Analysis, 2017 to 2022
6.2. Current and Future Volume (in Units) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Analysis
7.1. Regional Pricing Analysis By Product
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033
9.3.1. Endoscopic Suturing Devices
9.3.2. Endovascular Suturing Devices
9.3.3. Consumables
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
10.3.1. Gastrointestinal Procedures
10.3.2. Urological Procedures
10.3.3. Thoracic Procedures
10.3.4. Other Procedures
10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
11.3.1. Hospitals
11.3.2. Specialty Clinics
11.3.3. Independent Surgical Centers
11.3.4. Ambulatory Surgical Centers
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (Middle East & Africa)
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. USA
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Application
13.4.4. By End User
13.5. Country Level Analysis & Forecast
13.5.1. USA Market Analysis
13.5.1.1. Introduction
13.5.1.2. Market Analysis and Forecast by Market Taxonomy
13.5.1.2.1. By Product
13.5.1.2.2. By Application
13.5.1.2.3. By End User
13.5.2. Canada Market Analysis
13.5.2.1. Introduction
13.5.2.2. Market Analysis and Forecast by Market Taxonomy
13.5.2.2.1. By Product
13.5.2.2.2. By Application
13.5.2.2.3. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Country Level Analysis & Forecast
14.5.1. Brazil Market Analysis
14.5.1.1. Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Product
14.5.1.2.2. By Application
14.5.1.2.3. By End User
14.5.2. Mexico Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Product
14.5.2.2.2. By Application
14.5.2.2.3. By End User
14.5.3. Argentina Market Analysis
14.5.3.1. Introduction
14.5.3.2. Market Analysis and Forecast by Market Taxonomy
14.5.3.2.1. By Product
14.5.3.2.2. By Application
14.5.3.2.3. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. France
15.3.1.3. Italy
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. Russia
15.3.1.7. BENELUX
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By End User
15.5. Country Level Analysis & Forecast
15.5.1. Germany Market Analysis
15.5.1.1. Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Product
15.5.1.2.2. By Application
15.5.1.2.3. By End User
15.5.2. France Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Product
15.5.2.2.2. By Application
15.5.2.2.3. By End User
15.5.3. Italy Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Product
15.5.3.2.2. By Application
15.5.3.2.3. By End User
15.5.4. U.K. Market Analysis
15.5.4.1. Introduction
15.5.4.2. Market Analysis and Forecast by Market Taxonomy
15.5.4.2.1. By Product
15.5.4.2.2. By Application
15.5.4.2.3. By End User
15.5.5. Spain Market Analysis
15.5.5.1. Introduction
15.5.5.2. Market Analysis and Forecast by Market Taxonomy
15.5.5.2.1. By Product
15.5.5.2.2. By Application
15.5.5.2.3. By End User
15.5.6. Russia Market Analysis
15.5.6.1. Introduction
15.5.6.2. Market Analysis and Forecast by Market Taxonomy
15.5.6.2.1. By Product
15.5.6.2.2. By Application
15.5.6.2.3. By End User
15.5.7. BENELUX Market Analysis
15.5.7.1. Introduction
15.5.7.2. Market Analysis and Forecast by Market Taxonomy
15.5.7.2.1. By Product
15.5.7.2.2. By Application
15.5.7.2.3. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Country Level Analysis & Forecast
16.5.1. India Market Analysis
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product
16.5.1.2.2. By Application
16.5.1.2.3. By End User
16.5.2. Thailand Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product
16.5.2.2.2. By Application
16.5.2.2.3. By End User
16.5.3. Indonesia Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Product
16.5.3.2.2. By Application
16.5.3.2.3. By End User
16.5.4. Malaysia Market Analysis
16.5.4.1. Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Product
16.5.4.2.2. By Application
16.5.4.2.3. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Country Level Analysis & Forecast
17.5.1. China Market Analysis
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By Application
17.5.1.2.3. By End User
17.5.2. Japan Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product
17.5.2.2.2. By Application
17.5.2.2.3. By End User
17.5.3. South Korea Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Product
17.5.3.2.2. By Application
17.5.3.2.3. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.4.4. By End User
18.5. Country Level Analysis & Forecast
18.5.1. Australia Market Analysis
18.5.1.1. Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product
18.5.1.2.2. By Application
18.5.1.2.3. By End User
18.5.2. New Zealand Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product
18.5.2.2.2. By Application
18.5.2.2.3. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. Northern Africa
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Application
19.4.4. By End User
19.5. Country Level Analysis & Forecast
19.5.1. GCC Countries Market Analysis
19.5.1.1. Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Product
19.5.1.2.2. By Application
19.5.1.2.3. By End User
19.5.2. Türkiye Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Product
19.5.2.2.2. By Application
19.5.2.2.3. By End User
19.5.3. Northern Africa Market Analysis
19.5.3.1. Introduction
19.5.3.2. Market Analysis and Forecast by Market Taxonomy
19.5.3.2.1. By Product
19.5.3.2.2. By Application
19.5.3.2.3. By End User
19.5.4. South Africa Market Analysis
19.5.4.1. Introduction
19.5.4.2. Market Analysis and Forecast by Market Taxonomy
19.5.4.2.1. By Product
19.5.4.2.2. By Application
19.5.4.2.3. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
21. Competition Analysis
21.1. Competition Dashboard
21.2. Branding and Promotional Strategies, By Key Players
21.3. Key Development Analysis
21.4. Competition Deep Dive
21.4.1. Medtronic Plc.
21.4.1.1.1. Overview
21.4.1.2. Product Portfolio
21.4.1.3. Key Financials
21.4.1.4. Sales Footprint
21.4.1.5. SWOT Analysis
21.4.1.6. Strategy Overview
21.4.1.6.1. Marketing Strategy
21.4.1.6.2. Product Strategy
21.4.1.6.3. Channel Strategy
21.4.2. B Braun Melsungen
21.4.2.1.1. Overview
21.4.2.2. Product Portfolio
21.4.2.3. Key Financials
21.4.2.4. Sales Footprint
21.4.2.5. SWOT Analysis
21.4.2.6. Strategy Overview
21.4.2.6.1. Marketing Strategy
21.4.2.6.2. Product Strategy
21.4.2.6.3. Channel Strategy
21.4.3. Intuitive Medical
21.4.3.1.1. Overview
21.4.3.2. Product Portfolio
21.4.3.3. Key Financials
21.4.3.4. Sales Footprint
21.4.3.5. SWOT Analysis
21.4.3.6. Strategy Overview
21.4.3.6.1. Marketing Strategy
21.4.3.6.2. Product Strategy
21.4.3.6.3. Channel Strategy
21.4.4. Johnson & Johnson (Ethicon)
21.4.4.1.1. Overview
21.4.4.2. Product Portfolio
21.4.4.3. Key Financials
21.4.4.4. Sales Footprint
21.4.4.5. SWOT Analysis
21.4.4.6. Strategy Overview
21.4.4.6.1. Marketing Strategy
21.4.4.6.2. Product Strategy
21.4.4.6.3. Channel Strategy
21.4.5. Richard Wolf GmbH
21.4.5.1.1. Overview
21.4.5.2. Product Portfolio
21.4.5.3. Key Financials
21.4.5.4. Sales Footprint
21.4.5.5. SWOT Analysis
21.4.5.6. Strategy Overview
21.4.5.6.1. Marketing Strategy
21.4.5.6.2. Product Strategy
21.4.5.6.3. Channel Strategy
21.4.6. Karl Storz GmbH
21.4.6.1.1. Overview
21.4.6.2. Product Portfolio
21.4.6.3. Key Financials
21.4.6.4. Sales Footprint
21.4.6.5. SWOT Analysis
21.4.6.6. Strategy Overview
21.4.6.6.1. Marketing Strategy
21.4.6.6.2. Product Strategy
21.4.6.6.3. Channel Strategy
21.4.7. Olympus Corporation
21.4.7.1.1. Overview
21.4.7.2. Product Portfolio
21.4.7.3. Key Financials
21.4.7.4. Sales Footprint
21.4.7.5. SWOT Analysis
21.4.7.6. Strategy Overview
21.4.7.6.1. Marketing Strategy
21.4.7.6.2. Product Strategy
21.4.7.6.3. Channel Strategy
21.4.8. Teleflex Corporation
21.4.8.1.1. Overview
21.4.8.2. Product Portfolio
21.4.8.3. Key Financials
21.4.8.4. Sales Footprint
21.4.8.5. SWOT Analysis
21.4.8.6. Strategy Overview
21.4.8.6.1. Marketing Strategy
21.4.8.6.2. Product Strategy
21.4.8.6.3. Channel Strategy
21.4.9. Terumo Corporation
21.4.9.1.1. Overview
21.4.9.2. Product Portfolio
21.4.9.3. Key Financials
21.4.9.4. Sales Footprint
21.4.9.5. SWOT Analysis
21.4.9.6. Strategy Overview
21.4.9.6.1. Marketing Strategy
21.4.9.6.2. Product Strategy
21.4.9.6.3. Channel Strategy
21.4.10. Boston Scientific
21.4.10.1.1. Overview
21.4.10.2. Product Portfolio
21.4.10.3. Key Financials
21.4.10.4. Sales Footprint
21.4.10.5. SWOT Analysis
21.4.10.6. Strategy Overview
21.4.10.6.1. Marketing Strategy
21.4.10.6.2. Product Strategy
21.4.10.6.3. Channel Strategy
21.4.11. Apollo Endosurgery
21.4.11.1.1. Overview
21.4.11.2. Product Portfolio
21.4.11.3. Key Financials
21.4.11.4. Sales Footprint
21.4.11.5. SWOT Analysis
21.4.11.6. Strategy Overview
21.4.11.6.1. Marketing Strategy
21.4.11.6.2. Product Strategy
21.4.11.6.3. Channel Strategy
21.4.12. Cook Medical
21.4.12.1.1. Overview
21.4.12.2. Product Portfolio
21.4.12.3. Key Financials
21.4.12.4. Sales Footprint
21.4.12.5. SWOT Analysis
21.4.12.6. Strategy Overview
21.4.12.6.1. Marketing Strategy
21.4.12.6.2. Product Strategy
21.4.12.6.3. Channel Strategy
21.4.13. Cardinal Health
21.4.13.1.1. Overview
21.4.13.2. Product Portfolio
21.4.13.3. Key Financials
21.4.13.4. Sales Footprint
21.4.13.5. SWOT Analysis
21.4.13.6. Strategy Overview
21.4.13.6.1. Marketing Strategy
21.4.13.6.2. Product Strategy
21.4.13.6.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
Endoluminal Suturing Device Market
